VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
2668
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
482
Interactions with Platform & by Email
PARTICIPANTS
82
Unique # Participated
VALIDATIONS
37
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
111
PAGES
183
EDITION
9
PRICE
USD $4950
It Pays to Understand the Dynamics of Competition in Your Business Ecosystem.
Who Are Your Competitors in the Bovine Respiratory Disease Treatment Market?
Amid the COVID-19 crisis, the global market for Bovine Respiratory Disease Treatment estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 6.4% over the analysis period 2020-2027. Antibiotics, one of the segments analyzed in the report, is projected to record a 7.1% CAGR and reach US$476.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Vaccines segment is readjusted to a revised 6.2% CAGR for the next 7-year period.
The Bovine Respiratory Disease Treatment market in the U.S. is estimated at US$279.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$344.6 Million by the year 2027 trailing a CAGR of 9.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.
In the global Other Segments segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$208.6 Million in the year 2020 will reach a projected size of US$303.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$215.9 Million by the year 2027, while Latin America will expand at a 7.2% CAGR through the analysis period. We bring years of research experience to this 9th edition of our report. The 183-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Bayer AG; Bimeda Group; Boehringer Ingelheim International GmbH; Ceva Sante Animale; Elanco; Merck & Co., Inc.; Vetoquinol S.A.; Virbac Group; Zoetis Services LLC
» Segment (Antibiotics, Vaccines, Other Segments)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Bovine Respiratory Disease Treatment Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Bovine Respiratory Disease Treatment Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 |
| Bovine Respiratory Disease Treatment Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019 |
| Bovine Respiratory Disease Treatment Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 |
| Antibiotics (Segment) World Market by Region/Country in US$ Thousand: 2020 to 2027 |
| Antibiotics (Segment) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019 |
| Antibiotics (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Vaccines (Segment) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027 |
| Vaccines (Segment) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019 |
| Vaccines (Segment) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 |
| Other Segments (Segment) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027 |
| Other Segments (Segment) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019 |
| Other Segments (Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Bovine Respiratory Disease Treatment Market Share (in %) by Company: 2019 & 2025 |
| United States Bovine Respiratory Disease Treatment Market Estimates and Projections in US$ Thousand by Segment: 2020 to 2027 |
| Bovine Respiratory Disease Treatment Market in the United States by Segment: A Historic Review in US$ Thousand for 2012-2019 |
| United States Bovine Respiratory Disease Treatment Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| CANADA |
| Canadian Bovine Respiratory Disease Treatment Market Estimates and Forecasts in US$ Thousand by Segment: 2020 to 2027 |
| Canadian Bovine Respiratory Disease Treatment Historic Market Review by Segment in US$ Thousand: 2012-2019 |
| Bovine Respiratory Disease Treatment Market in Canada: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027 |
| JAPAN |
| Japanese Market for Bovine Respiratory Disease Treatment: Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2020-2027 |
| Bovine Respiratory Disease Treatment Market in Japan: Historic Sales Analysis in US$ Thousand by Segment for the Period 2012-2019 |
| Japanese Bovine Respiratory Disease Treatment Market Share Analysis by Segment: 2012 VS 2020 VS 2027 |
| CHINA |
| Chinese Bovine Respiratory Disease Treatment Market Growth Prospects in US$ Thousand by Segment for the Period 2020-2027 |
| Bovine Respiratory Disease Treatment Historic Market Analysis in China in US$ Thousand by Segment: 2012-2019 |
| Chinese Bovine Respiratory Disease Treatment Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| EUROPE |
| Market Facts & Figures |
| European Bovine Respiratory Disease Treatment Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Bovine Respiratory Disease Treatment Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027 |
| Bovine Respiratory Disease Treatment Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019 |
| European Bovine Respiratory Disease Treatment Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 |
| European Bovine Respiratory Disease Treatment Market Estimates and Forecasts in US$ Thousand by Segment: 2020-2027 |
| Bovine Respiratory Disease Treatment Market in Europe in US$ Thousand by Segment: A Historic Review for the Period 2012-2019 |
| European Bovine Respiratory Disease Treatment Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| FRANCE |
| Bovine Respiratory Disease Treatment Market in France by Segment: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| French Bovine Respiratory Disease Treatment Historic Market Scenario in US$ Thousand by Segment: 2012-2019 |
| French Bovine Respiratory Disease Treatment Market Share Analysis by Segment: 2012 VS 2020 VS 2027 |
| GERMANY |
| Bovine Respiratory Disease Treatment Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Segment for the Period 2020-2027 |
| German Bovine Respiratory Disease Treatment Historic Market Analysis in US$ Thousand by Segment: 2012-2019 |
| German Bovine Respiratory Disease Treatment Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| ITALY |
| Italian Bovine Respiratory Disease Treatment Market Growth Prospects in US$ Thousand by Segment for the Period 2020-2027 |
| Bovine Respiratory Disease Treatment Historic Market Analysis in Italy in US$ Thousand by Segment: 2012-2019 |
| Italian Bovine Respiratory Disease Treatment Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| UNITED KINGDOM |
| United Kingdom Market for Bovine Respiratory Disease Treatment: Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2020-2027 |
| Bovine Respiratory Disease Treatment Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Segment for the Period 2012-2019 |
| United Kingdom Bovine Respiratory Disease Treatment Market Share Analysis by Segment: 2012 VS 2020 VS 2027 |
| SPAIN |
| Spanish Bovine Respiratory Disease Treatment Market Estimates and Forecasts in US$ Thousand by Segment: 2020 to 2027 |
| Spanish Bovine Respiratory Disease Treatment Historic Market Review by Segment in US$ Thousand: 2012-2019 |
| Bovine Respiratory Disease Treatment Market in Spain: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027 |
| RUSSIA |
| Russian Bovine Respiratory Disease Treatment Market Estimates and Projections in US$ Thousand by Segment: 2020 to 2027 |
| Bovine Respiratory Disease Treatment Market in Russia by Segment: A Historic Review in US$ Thousand for 2012-2019 |
| Russian Bovine Respiratory Disease Treatment Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe Bovine Respiratory Disease Treatment Market Estimates and Forecasts in US$ Thousand by Segment: 2020-2027 |
| Bovine Respiratory Disease Treatment Market in Rest of Europe in US$ Thousand by Segment: A Historic Review for the Period 2012-2019 |
| Rest of Europe Bovine Respiratory Disease Treatment Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Bovine Respiratory Disease Treatment Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 |
| Bovine Respiratory Disease Treatment Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2012-2019 |
| Asia-Pacific Bovine Respiratory Disease Treatment Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027 |
| Bovine Respiratory Disease Treatment Market in Asia-Pacific by Segment: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| Asia-Pacific Bovine Respiratory Disease Treatment Historic Market Scenario in US$ Thousand by Segment: 2012-2019 |
| Asia-Pacific Bovine Respiratory Disease Treatment Market Share Analysis by Segment: 2012 VS 2020 VS 2027 |
| AUSTRALIA |
| Bovine Respiratory Disease Treatment Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Segment for the Period 2020-2027 |
| Australian Bovine Respiratory Disease Treatment Historic Market Analysis in US$ Thousand by Segment: 2012-2019 |
| Australian Bovine Respiratory Disease Treatment Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| INDIA |
| Indian Bovine Respiratory Disease Treatment Market Estimates and Forecasts in US$ Thousand by Segment: 2020 to 2027 |
| Indian Bovine Respiratory Disease Treatment Historic Market Review by Segment in US$ Thousand: 2012-2019 |
| Bovine Respiratory Disease Treatment Market in India: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027 |
| SOUTH KOREA |
| Bovine Respiratory Disease Treatment Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Segment for the Period 2020-2027 |
| South Korean Bovine Respiratory Disease Treatment Historic Market Analysis in US$ Thousand by Segment: 2012-2019 |
| Bovine Respiratory Disease Treatment Market Share Distribution in South Korea by Segment: 2012 VS 2020 VS 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Market for Bovine Respiratory Disease Treatment: Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2020-2027 |
| Bovine Respiratory Disease Treatment Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Segment for the Period 2012-2019 |
| Rest of Asia-Pacific Bovine Respiratory Disease Treatment Market Share Analysis by Segment: 2012 VS 2020 VS 2027 |
| LATIN AMERICA |
| Latin American Bovine Respiratory Disease Treatment Market Trends by Region/Country in US$ Thousand: 2020-2027 |
| Bovine Respiratory Disease Treatment Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2012-2019 |
| Latin American Bovine Respiratory Disease Treatment Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027 |
| Latin American Bovine Respiratory Disease Treatment Market Growth Prospects in US$ Thousand by Segment for the Period 2020-2027 |
| Bovine Respiratory Disease Treatment Historic Market Analysis in Latin America in US$ Thousand by Segment: 2012-2019 |
| Latin American Bovine Respiratory Disease Treatment Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| ARGENTINA |
| Argentinean Bovine Respiratory Disease Treatment Market Estimates and Forecasts in US$ Thousand by Segment: 2020-2027 |
| Bovine Respiratory Disease Treatment Market in Argentina in US$ Thousand by Segment: A Historic Review for the Period 2012-2019 |
| Argentinean Bovine Respiratory Disease Treatment Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| BRAZIL |
| Bovine Respiratory Disease Treatment Market in Brazil by Segment: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| Brazilian Bovine Respiratory Disease Treatment Historic Market Scenario in US$ Thousand by Segment: 2012-2019 |
| Brazilian Bovine Respiratory Disease Treatment Market Share Analysis by Segment: 2012 VS 2020 VS 2027 |
| MEXICO |
| Bovine Respiratory Disease Treatment Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Segment for the Period 2020-2027 |
| Mexican Bovine Respiratory Disease Treatment Historic Market Analysis in US$ Thousand by Segment: 2012-2019 |
| Mexican Bovine Respiratory Disease Treatment Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Bovine Respiratory Disease Treatment Market Estimates and Projections in US$ Thousand by Segment: 2020 to 2027 |
| Bovine Respiratory Disease Treatment Market in Rest of Latin America by Segment: A Historic Review in US$ Thousand for 2012-2019 |
| Rest of Latin America Bovine Respiratory Disease Treatment Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| MIDDLE EAST |
| The Middle East Bovine Respiratory Disease Treatment Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 |
| Bovine Respiratory Disease Treatment Market in the Middle East by Region/Country in US$ Thousand: 2012-2019 |
| The Middle East Bovine Respiratory Disease Treatment Market Share Breakdown by Region/Country: 2012, 2020, and 2027 |
| The Middle East Bovine Respiratory Disease Treatment Market Estimates and Forecasts in US$ Thousand by Segment: 2020 to 2027 |
| The Middle East Bovine Respiratory Disease Treatment Historic Market by Segment in US$ Thousand: 2012-2019 |
| Bovine Respiratory Disease Treatment Market in the Middle East: Percentage Share Breakdown of Sales by Segment for 2012,2020, and 2027 |
| IRAN |
| Iranian Market for Bovine Respiratory Disease Treatment: Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2020-2027 |
| Bovine Respiratory Disease Treatment Market in Iran: Historic Sales Analysis in US$ Thousand by Segment for the Period 2012-2019 |
| Iranian Bovine Respiratory Disease Treatment Market Share Analysis by Segment: 2012 VS 2020 VS 2027 |
| ISRAEL |
| Israeli Bovine Respiratory Disease Treatment Market Estimates and Forecasts in US$ Thousand by Segment: 2020-2027 |
| Bovine Respiratory Disease Treatment Market in Israel in US$ Thousand by Segment: A Historic Review for the Period 2012-2019 |
| Israeli Bovine Respiratory Disease Treatment Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| SAUDI ARABIA |
| Saudi Arabian Bovine Respiratory Disease Treatment Market Growth Prospects in US$ Thousand by Segment for the Period 2020-2027 |
| Bovine Respiratory Disease Treatment Historic Market Analysis in Saudi Arabia in US$ Thousand by Segment: 2012-2019 |
| Saudi Arabian Bovine Respiratory Disease Treatment Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| UNITED ARAB EMIRATES |
| Bovine Respiratory Disease Treatment Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Segment for the Period 2020-2027 |
| United Arab Emirates Bovine Respiratory Disease Treatment Historic Market Analysis in US$ Thousand by Segment: 2012-2019 |
| Bovine Respiratory Disease Treatment Market Share Distribution in United Arab Emirates by Segment: 2012 VS 2020 VS 2027 |
| REST OF MIDDLE EAST |
| Bovine Respiratory Disease Treatment Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Segment for the Period 2020-2027 |
| Rest of Middle East Bovine Respiratory Disease Treatment Historic Market Analysis in US$ Thousand by Segment: 2012-2019 |
| Rest of Middle East Bovine Respiratory Disease Treatment Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| AFRICA |
| African Bovine Respiratory Disease Treatment Market Estimates and Projections in US$ Thousand by Segment: 2020 to 2027 |
| Bovine Respiratory Disease Treatment Market in Africa by Segment: A Historic Review in US$ Thousand for 2012-2019 |
| African Bovine Respiratory Disease Treatment Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 5 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com